• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»nutraceuticals

Why PureHealth Research’s berberine GLP-1 supplement push enters a crowded evidence debate

By Pallavi Madhiraju on May 9, 2026   Pharma & Biotech  

Why PureHealth Research’s berberine GLP-1 supplement push enters a crowded evidence debate

GLP-1 demand is reshaping supplements. PureHealth Research’s berberine launch tests where wellness claims meet evidence and regulation.

How PureHealth Research LLC’s VenEase highlights gaps between compression therapy and clinical intervention

By Pallavi Madhiraju on February 14, 2026   Pharma & Biotech  

How PureHealth Research LLC’s VenEase highlights gaps between compression therapy and clinical intervention

Explore why vein health supplements like VenEase are gaining traction, what they change in circulation care, and the risks regulators and clinicians are watching.

Anathapindika Health expands retail footprint, testing detox-first nutraceutical demand in specialty stores

By Soujanya Ravi on February 6, 2026   Features & Analysis  

Anathapindika Health expands retail footprint, testing detox-first nutraceutical demand in specialty stores

Discover what Anathapindika Health’s AlchePharma retail expansion signals for detox-focused nutraceuticals and the evolving wellness retail landscape.

Why Brightseed’s glycemic control data could reshape how GLP-1 companion products are evaluated

By Pallavi Madhiraju on February 5, 2026   Pharma & Biotech  

Why Brightseed’s glycemic control data could reshape how GLP-1 companion products are evaluated

Peer-reviewed data puts Brightseed’s BioMetaControl under the clinical microscope. Find out what this trial means for GLP-1 companions and metabolic care.

What Purity Products UROX formula reveals about the future of urological wellness

By Pallavi Madhiraju on December 31, 2025   Pharma & Biotech  

What Purity Products UROX formula reveals about the future of urological wellness

A representative image depicting natural supplement capsules, reinforcing the rise of clinically formulated nutraceuticals like MyBladder® in urological wellness.

Recent Posts

  • Can Servier’s $2.65bn Edgewise deal reshape the muscular dystrophy drug race?
  • Can Convergent Therapeutics define the next prostate cancer standard after Lu-PSMA therapy?
  • Why T-CURX’s Pantherna acquisition could matter for the future of cell therapy manufacturing
  • Is Amgen’s bispecific lung cancer drug becoming a global standard after chemotherapy failure?
  • Fulgent Genetics’ oncology pivot gets sharper as FID-007 shows Phase 2 activity at ASCO 2026
  • Minghui and Qilu push MHB088C forward as prostate cancer ADC race tightens
  • Why Aphranel’s EU MDR approval could sharpen competition in CaHA dermal fillers
  • Oricell’s ASCO 2026 liver cancer data put GPC3 CAR-T back in the spotlight
  • Can Lilly turn Hanmi’s sonefpeglutide into the next long-acting GLP-2 rare disease bet?
  • Can enicepatide and petrelintide help Genentech build a differentiated obesity franchise?
  • Can Summit and Akeso turn ivonescimab into a global lung cancer challenger?
  • Why Tempus AI’s Lens upgrade matters for precision oncology drug development
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes